BioSpace News Archive

MODAG announced the completion of a EUR 12 million Series A financing round, launching out of stealth mode to advance lead candidate anle138b into clinical development in Multiple System Atrophy (MSA).

Collaboration furthers Elanco’s commitment to antibiotic stewardship and offering alternatives to pork producers’ most difficult challenges

Company Will Prioritize Continued Development of Mirvetuximab Soravtansine and a Select Portfolio of Earlier-Stage Candidates

Co-Diagnostics, Inc. announced that Dr. Eugene Durenard and Mr. Ted Murphy have joined the Board of Directors of Co-Diagnostics, and will serve on the Board’s Compensation and Corporate Governance/Nominating Committees and Audit Committees as independent directors.

LifeMax Laboratories, Inc. announced that the Food & Drug Administration granted orphan drug designation to LM-030, an investigational therapy licensed from Novartis and ready to enter into pivotal clinical trials for the treatment of Netherton Syndrome.

Vaxess Technologies, a biotechnology company redefining drug delivery with the silk-powered MIMIX smart release patch, announced it has closed the final tranche of an $8.2 million Series A round.

OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced that it has entered into a collaboration with Dana-Farber Cancer Institute,

Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that television personality, podcaster, comedian and beauty expert to the stars Jonathan Van Ness has joined Biossance as the first celebrity ambassador for the brand.

DURECT Corporation (Nasdaq: DRRX) today announced it has submitted a full response to the Complete Response Letter (CRL) it previously received from U.S. Food and Drug Administration (FDA) related to POSIMIR® (bupivacaine extended-release solution).

The study was commissioned by the Personalized Medicine Coalition